| DOXGX | PNEAX | DOXGX / PNEAX | |
| Total Expense Ratio | 0.41 | 1.03 | 40% |
| Annual Report Gross Expense Ratio | 0.46 | 1.03 | 45% |
| Fund Existence | 4 years | 24 years | - |
| Gain YTD | 29.622 | 3.133 | 946% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 119B | 476M | 25,000% |
| Annual Yield % from dividends | 1.43 | 1.93 | 74% |
| Returns for 1 year | 24.26 | -4.27 | -568% |
| Returns for 3 years | 149.28 | -3.33 | -4,487% |
| Returns for 5 years | N/A | 7.45 | - |
| Returns for 10 years | N/A | -22.50 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FNGD | 5.13 | 0.20 | +4.06% |
| MicroSectors™ FANG+™ -3X Invrs Lvrgd ETN | |||
| EPMV | 22.08 | N/A | N/A |
| Harbor Mid Cap Value ETF | |||
| GFEB | 40.50 | -0.13 | -0.32% |
| FT Vest U.S. Eq Mod Buffr ETF - Feb | |||
| QVML | 39.00 | -0.26 | -0.66% |
| Invesco S&P 500 QVM Multi-factor ETF | |||
| BIS | 9.94 | -0.13 | -1.29% |
| ProShares UltraShort Nasdaq Biotech | |||